These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33649299)

  • 1. Mutation D614G increases SARS-CoV-2 transmission.
    Arora P; Pöhlmann S; Hoffmann M
    Signal Transduct Target Ther; 2021 Mar; 6(1):101. PubMed ID: 33649299
    [No Abstract]   [Full Text] [Related]  

  • 2. The Spike D614G mutation increases SARS-CoV-2 infection of multiple human cell types.
    Daniloski Z; Jordan TX; Ilmain JK; Guo X; Bhabha G; tenOever BR; Sanjana NE
    Elife; 2021 Feb; 10():. PubMed ID: 33570490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Genetic Variability in ACE2 Expression on the Evolutionary Dynamics of SARS-CoV-2 Spike D614G Mutation.
    Huang SW; Miller SO; Yen CH; Wang SF
    Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33374416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Connections between biomechanics and higher infectivity: a tale of the D614G mutation in the SARS-CoV-2 spike protein.
    Mittal A; Verma V
    Signal Transduct Target Ther; 2021 Jan; 6(1):11. PubMed ID: 33431822
    [No Abstract]   [Full Text] [Related]  

  • 5. D614G and SARS-CoV-2 replication fitness.
    Engelman KD; Engelman AN
    Signal Transduct Target Ther; 2021 Mar; 6(1):99. PubMed ID: 33649290
    [No Abstract]   [Full Text] [Related]  

  • 6. Bimodular effects of D614G mutation on the spike glycoprotein of SARS-CoV-2 enhance protein processing, membrane fusion, and viral infectivity.
    Jiang X; Zhang Z; Wang C; Ren H; Gao L; Peng H; Niu Z; Ren H; Huang H; Sun Q
    Signal Transduct Target Ther; 2020 Nov; 5(1):268. PubMed ID: 33203835
    [No Abstract]   [Full Text] [Related]  

  • 7. Could the D614G substitution in the SARS-CoV-2 spike (S) protein be associated with higher COVID-19 mortality?
    Eaaswarkhanth M; Al Madhoun A; Al-Mulla F
    Int J Infect Dis; 2020 Jul; 96():459-460. PubMed ID: 32464271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher binding affinity of furin for SARS-CoV-2 spike (S) protein D614G mutant could be associated with higher SARS-CoV-2 infectivity.
    Mohammad A; Alshawaf E; Marafie SK; Abu-Farha M; Abubaker J; Al-Mulla F
    Int J Infect Dis; 2021 Feb; 103():611-616. PubMed ID: 33075532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular epidemiology of SARS-CoV-2 isolated from COVID-19 family clusters.
    Gunadi ; Wibawa H; Hakim MS; Marcellus ; Trisnawati I; Khair RE; Triasih R; Irene ; Afiahayati ; Iskandar K; Siswanto ; Anggorowati N; Daniwijaya EW; Supriyati E; Nugrahaningsih DAA; Budiono E; Retnowulan H; Puspadewi Y; Puspitawati I; Sianipar O; Afandy D; Simanjaya S; Widitjiarso W; Puspitarani DA; Fahri F; Riawan U; Fauzi AR; Kalim AS; Ananda NR; Setyati A; Setyowireni D; Laksanawati IS; Arguni E; Nuryastuti T; Wibawa T;
    BMC Med Genomics; 2021 Jun; 14(1):144. PubMed ID: 34074255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a PCR-RFLP method for detection of D614G mutation in SARS-CoV-2.
    Hashemi SA; Khoshi A; Ghasemzadeh-Moghaddam H; Ghafouri M; Taghavi M; Namdar-Ahmadabad H; Azimian A
    Infect Genet Evol; 2020 Dec; 86():104625. PubMed ID: 33166683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phylogenomic analysis of SARS-CoV-2 from third wave clusters in Malaysia reveals dominant local lineage B.1.524 and persistent spike mutation A701V.
    Suppiah J; Kamel KA; Mohd-Zawawi Z; Afizan MA; Yahya H; Md-Hanif SA; Thayan R
    Trop Biomed; 2021 Sep; 38(3):289-293. PubMed ID: 34362872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways.
    Laporte M; Raeymaekers V; Van Berwaer R; Vandeput J; Marchand-Casas I; Thibaut HJ; Van Looveren D; Martens K; Hoffmann M; Maes P; Pöhlmann S; Naesens L; Stevaert A
    PLoS Pathog; 2021 Apr; 17(4):e1009500. PubMed ID: 33886690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modelling the association between COVID-19 transmissibility and D614G substitution in SARS-CoV-2 spike protein: using the surveillance data in California as an example.
    Zhao S; Lou J; Cao L; Zheng H; Chong MKC; Chen Z; Zee BCY; Chan PKS; Wang MH
    Theor Biol Med Model; 2021 Mar; 18(1):10. PubMed ID: 33750399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of SARS-CoV-2 Envelope, Membrane, Nucleocapsid, and Spike Structural Proteins from the Beginning of the Pandemic to September 2020: A Global and Regional Approach by Epidemiological Week.
    Troyano-Hernáez P; Reinosa R; Holguín Á
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33557213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The extent of molecular variation in novel SARS-CoV-2 after the six-month global spread.
    Bui NN; Lin YT; Huang SH; Lin CW
    Infect Genet Evol; 2021 Jul; 91():104800. PubMed ID: 33677109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 reinfection with a virus harboring mutation in the Spike and the Nucleocapsid proteins in Panama.
    Díaz Y; Ortiz A; Weeden A; Castillo D; González C; Moreno B; Martínez-Montero M; Castillo M; Vasquez G; Sáenz L; Franco D; Pitti Y; Chavarria O; Gondola J; Moreno AM; Ábrego L; Beltrán D; Guerra I; Chang J; Chaverra Z; Guerrero I; Valoy A; Gaitán M; Araúz D; Morán E; Chen-Germán M; Valdespino E; Rodríguez R; Corrales R; Chen-Camaño R; Pascale JM; Martínez AA; López-Vergès S;
    Int J Infect Dis; 2021 Jul; 108():588-591. PubMed ID: 34107326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.
    Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multisystem Inflammatory Syndrome in Children in February 2020 and Implications of Genomic Sequencing for SARS-CoV-2.
    Parsons E; Timlin M; Starr C; Fries A; Wells R; Studer M; Sainato R
    J Pediatric Infect Dis Soc; 2021 May; 10(5):695-697. PubMed ID: 33336251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation in a SARS-CoV-2 Haplotype from Sub-Antarctic Chile Reveals New Insights into the Spike's Dynamics.
    González-Puelma J; Aldridge J; Montes de Oca M; Pinto M; Uribe-Paredes R; Fernández-Goycoolea J; Alvarez-Saravia D; Álvarez H; Encina G; Weitzel T; Muñoz R; Olivera-Nappa Á; Pantano S; Navarrete MA
    Viruses; 2021 May; 13(5):. PubMed ID: 34064904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Genetic Variant of SARS-CoV-2: would It Matter for Controlling the Devastating Pandemic?
    Guo S; Liu K; Zheng J
    Int J Biol Sci; 2021; 17(6):1476-1485. PubMed ID: 33907511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.